Lifeward (LFWD) Convertible Debt (2026)
Lifeward's (LFWD) quarterly Convertible Debt came in at $4.4 million in Q2 2026, down 39.09% quarter-over-quarter from $7.3 million in Q1 2026.
Powered by 
Analysis
Lifeward (LFWD) Convertible Debt (2026) Analysis & Trends
Lifeward has disclosed Convertible Debt across 1 years of filings, most recently posting $4.4 million for Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Lifeward | 19.77 Mn | 10.32 Mn | 2.71 Mn |